To shed some light on the possible mechanisms underlying the anti-lymphangiogenic effect exerted by SSc serum on LMVECs, we investigated whether it could induce any relevant changes in the expression of cell surface receptors, which act as important mediators of the pro-lymphangiogenic activity of VEGF-C. Here, CD177 is linked to systemic sclerosis.